Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Korea To Expand Drug Support Incentives, Ease Listing Requirements

This article was originally published in PharmAsia News

Executive Summary

South Korea is seeking to nurture the health care industry by new means such as easing the requirements for bioventures to stay listed on the Kosdaq market, as well as through drug development incentives such as extended tax benefits. The plan is part of a broader government measures to prop up investments in industries.



Related Companies